Anest. intenziv. Med. 2007;18(6):340-344

Neuromodulation in chronic pain managementAlgeziology

M. Hakl1, P. Ševčík2
1 Centrum pro léčbu bolesti Anesteziologicko-resuscitační kliniky FN u sv. Anny v Brně a LF MU Brno
2 Klinika anesteziologie, resuscitace a intenzivní medicíny FN Brno a LF MU Brno

Neuromodulation methods include management strategies employing the application of agents or a defined electric current directly to the nerve structures. Modern neurostimulation management is based on the concept of the gate theory of pain formulated by Melzack and Wall in 1965. The principle of spinal cord stimulation is based on an increased release of inhibitor substances (endorphins, enkephalins, dynorpfines). Segmental spinal mechanisms play an important role in the therapeutic effect. Spinal cord stimulation is suitable in the treatment of chronic neuropathic and ischaemic pain. In appropriately selected patients very good results are achievable up to a decrease of the VAS pain score from 8-10 to 0-2. Implanted intrathecal drug delivery systems are indicated in some severe types of chronic pain especially of the nociceptive character, or in severe forms of central spastic syndromes.The implantable pumps can be crudely divided into programmable and non-programmable.The fundamental analgesic for long-term intrathecal application is morphine and for intrathecal spasticity treatment it is baclofen. Neuromodulation methods are reserved for a relatively narrow group of patients suffering from chronic pain syndromes unresponsive to other strategies. When used correctly their efficacy greatly exceeds the efficacy of the classic farmacological approach.

Keywords: spinal cord stimulation; cortical stimulation; implantable intrathecal drug application systems; neuropathic pain; morphine; baclofen

Published: December 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hakl M, Ševčík P. Neuromodulation in chronic pain management. Anest. intenziv. Med. 2007;18(6):340-344.
Download citation

References

  1. Kozák, J., Vrba, I., Masopust, V., Rokyta, R. Neuromodulace v léčbě chronické bolesti. In Rokyta, R., Kršiak, M., Kozák, J. Bolest. Tigis : Praha 2006, s. 551-578.
  2. Hassenbusch, S. J., Nicka, M. S., Schopna, D. Long term results of peripherial nerve stimulation for reflex symphatetic dystrophy. J. Neurosurg., 1996, 7, p. 415-423. Go to original source... Go to PubMed...
  3. Tsubokawa, T., Katayama, Y., Yamamoto, T. Motor cortex stimulation for control of thalamic pain. 6th Word Congress of Pain, Adelaide. Abstracts, Pain 491.
  4. Simpson, B. A., Bjorn, A. Spinal cord and brain stimulation. In: Wall and Melzack's Textbook of Pain, 5th Edition, London : Churchil Livingstone 2006, p. 563-582. Go to original source...
  5. Ševčík, P., Hakl, M., Vrba, I., Houdek, M., Kozák, J., Haklová, O., Dadák, L. Míšní neuromodulace v České republice - kam jsme došli v roce 2003? In Sborník vyžádaných přednášek 10. kongresu ČSARIM ČLS JEP. ČSARIM 2003, s. 44-46.
  6. Bennett, G., Burchiel, K., Buchser, E. et al. Clinical guidelines for intraspinal infusion: report of an expert panel. J. Pain Symptom Manag., 2000, p. 37-43. Go to original source... Go to PubMed...
  7. Yaksh, T. L., Hassenbusch, S., Burchiel, K. et al. Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Medicine, 2002, 10, p. 3-8. Go to original source... Go to PubMed...
  8. Hassenbusch, S. J., Burchiel, K., Coffey, R. J. et al. Management of intrathecal catheter-tip inflammatory masses: a consensus statement. Pain Medicine, 2002, 4, p. 13-18. Go to original source... Go to PubMed...
  9. Cousins, M. J., Walker, S. M., Gouda, L. C., Carr, D. B. Spinal opioid and non-opioid drugs. IARS Review Course Lectures, 2002, p. 38-44.
  10. Sedral, J. M., Marks, R. L., Morley, S. J., Goodchild, C. S. Intrathecal midazolam for the treatment of chronic mechanical low back pain: a controlled comparison with epidural steroid in a pilot study. Pain, 1992, 48, p. 5-12. Go to original source... Go to PubMed...
  11. Yang, C. Y., Wong, C. S., Chány, J. Y. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can. J. Anaesth., 1996, 43, p. 379-383. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.